Steven Cohen’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.74M Buy
5,109,974
+129,448
+3% +$265K 0.01% 1433
2026
Q2
$12.2M Sell
4,980,526
-984,152
-16% -$2.25M 0.01% 1169
2026
Q1
$13.5M Buy
5,964,678
+3,047
+0.1% +$6.41K 0.02% 1039
2025
Q4
$5.93M Buy
+5,961,631
New +$3.64M 0.01% 1714
2023
Q1
– Sell
-82,100
Closed -$421K – 2390
2022
Q4
$421K Sell
82,100
-83,100
-50% -$784K ﹤0.01% 1165
2022
Q3
$1.63M Sell
165,200
-315,800
-66% -$3.33M 0.01% 970
2022
Q2
$4.04M Buy
481,000
+13,610
+3% +$133K 0.02% 763
2022
Q1
$5.88M Buy
467,390
+56,590
+14% +$750K 0.02% 657
2021
Q4
$6.52M Buy
+410,800
New +$7.72M 0.03% 618

Other funds holding IPSC

Steven Cohen's IPSC Position: Q3 2026 in Review

Steven Cohen increased its Century Therapeutics (IPSC) stake by 2.6% in Q3 2026, buying an estimated $265K and bringing the position to 5,109,974 shares worth $8.74M. The position accounts for 0.01% of the portfolio, ranked #1433.

Steven Cohen first reported a position in IPSC in Q4 2021 and has held it in 9 quarters since. The position peaked at $13.5M in Q1 2026. 100 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Steven Cohen held 5,109,974 shares of Century Therapeutics worth $8.74M as of Q3 2026.
  • Steven Cohen bought 129,448 Century Therapeutics shares in Q3 2026, an estimated $265K.
  • Century Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1433 holding.
  • Steven Cohen first reported a position in Century Therapeutics in Q4 2021 and has held it in 9 quarters since.
  • Steven Cohen's Century Therapeutics position peaked at $13.5M in Q1 2026.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.